Category: | Health, |
---|---|
Address: | 209 Dundas St E., Post Office Box 31 Whitby, Whitby, ON L1N 5R7, Canada |
Postal code: | L1N 5R7 |
Phone: | (844) 493-7922 |
Website: | http://www.hydrx.ca/ |
Monday: | 8:30 AM – 4:30 PM |
---|---|
Tuesday: | 8:30 AM – 4:30 PM |
Wednesday: | 8:30 AM – 4:30 PM |
Thursday: | 8:30 AM – 4:30 PM |
Friday: | 8:30 AM – 4:30 PM |
Saturday: | Closed |
Sunday: | Closed |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about HydRx Farms Ltd., use the form below and your opinion, advice or comment will appear in this space.
209 Dundas St. E, PO Box 31 Whitby, Whitby ON L1N 5R7 Phone: +1 844 493.7922 Email: info@hydrx.ca
209 Dundas St. E, PO Box 31 Whitby, Whitby ON L1N 5R7 Phone: +1 844 493.7922 Email: info@hydrx.ca
Company profile & key executives for HydRx Farms Ltd (1363760D:-) including description, corporate address, management team and contact info.
HydRx Farms Ltd. is a vertically-integrated biopharmaceutical Licensed Dealer with a focus on developing and commercializing ... 1-844-493-7922. Website. hydrx.ca.
See more of HydRx Farms Ltd on Facebook. Log In. or. ... (844) 493-7922. Contact HydRx Farms Ltd on Messenger. www.hydrx.ca. Pharmaceutical Company. Price Range ...
HydRx Farms Ltd., Health clinic in Whitby, Ontario, 1130 Champlain Court, Whitby, ON L1N 6K9 - Hours of Operation & Customer Reviews.
HydRx Farms Ltd. (d/b/a Scientus Pharma Inc.) Announces Completion of its $15.8 Million Private Placement Offering of Common Shares. ... +1 844 493.7922. 209 Dundas St. E
HydRx Farms Ltd. HydRx is a vertically-integrated biopharmaceutical Licensed Dealer under the Narcotics Control Regulations of Canada with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products.
Licensed & Approved by Health Canada September 22, 2017 Licence Type Profile. HydRx is a vertically-integrated biopharmaceutical Licensed Dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products.
For further information contact: Mr. Trevor Folk Chief Executive Officer tfolk@scientuspharma.com 1 (844) 493-7922 Mr. Har Grover Executive Chairman